These results indicated that the expression levels of CBX1, CBX3, CBX4, CBX5, CBX6, CBX7, and CBX8 were significantly associated with ccRCC patient prognosis, and they might be exploited as useful biomarkers for predicting the survival of patients with ccRCC. Here, CBX6 is linked to nonpapillary renal cell carcinoma.